News

Biotalys Gains Approval for EVOCA Trials in Greenhouses

Biotalys Gains Approval for EVOCA Trials in Greenhouses

Biotalys Receives Approval for Large-Scale EVOCA Trials

Biotalys, a pioneering company in Agricultural Technology (AgTech), is advancing sustainable crop protection with its first biofungicide candidate, EVOCA. Recently, the Dutch regulatory body CTGB approved large-scale demonstration trials in greenhouses, marking a significant milestone for the company.

Significance of EVOCA Trials

This approval enables Biotalys to conduct extensive trials to assess EVOCA's effectiveness against powdery mildew affecting tomatoes, cucumbers, and strawberries. The trials will take place across 40 hectares of tomatoes, 20 hectares of cucumbers, and 10 hectares of strawberries. A noteworthy aspect of this initiative is that the harvested produce can be sold for human consumption, avoiding the usual requirement for crop destruction that comes with unapproved crop protection products.

Expert Perspectives on Innovative Solutions

Jeannette Vriend, a plant protection expert from a leading Dutch growers association, expressed her excitement about this technological progress. She emphasized the urgent need for sustainable solutions to tackle fungal diseases, which have become increasingly difficult to control due to the declining availability of traditional crop protection products. This large-scale testing opportunity represents a hopeful shift towards integrating eco-friendly solutions in high-value crops.

Regulatory Confidence

Biotalys' commitment to safety and efficacy has fostered confidence in EVOCA's approval. Eva Van Hende, the Head of Regulatory and Sustainability at Biotalys, highlighted the importance of the Dutch authority's decision. The Netherlands is a key player in European agriculture, serving both as a major exporter of fruits and vegetables and as a rapporteur Member State for Biotalys' regulatory dossier at the European level.

Exploring EVOCA's Capabilities

EVOCA represents a significant advancement in agricultural technology, featuring a novel protein-based biofungicide. Its unique formulation has earned a new resistance classification from the Fungicide Resistance Action Committee (FRAC), positioning it as a potentially safe and effective solution for managing fungal diseases like botrytis and powdery mildew across various crops and climates. Moreover, EVOCA is currently under review by the U.S. Environmental Protection Agency (EPA) and is awaiting regulatory approval in the European Union.

Looking Ahead with AGROBODY Technology

In the future, EVOCA is set to pave the way for the upcoming product EVOCA NG, which is anticipated to be Biotalys’ first commercial fungicide derived from its AGROBODY technology platform. This development could represent a significant addition to the biocontrol portfolio, furthering the company's mission to provide safer and more sustainable agricultural solutions.

About Biotalys

Founded in 2013 as a spin-off from the Flanders Institute for Biotechnology (VIB), Biotalys is dedicated to transforming crop protection practices. The company focuses on developing protein-based biocontrol solutions that serve as alternatives to traditional chemical pesticides, ensuring a safer food supply chain. With an emphasis on innovation and sustainability, Biotalys is actively tackling major crop pests and diseases, enhancing the agricultural value chain from soil to plate.

Frequently Asked Questions

What is Biotalys' recent achievement?

Biotalys has received approval for large-scale demonstration trials of its biofungicide EVOCA in greenhouses.

What crops are included in the EVOCA trials?

The trials will include tomatoes, cucumbers, and strawberries.

Can the harvested produce be sold?

Yes, produce from these trials can be sold for human consumption, which is typically not allowed without prior regulatory approval.

What is the significance of the trials for Biotalys?

The trials provide an opportunity to demonstrate EVOCA's effectiveness and safety while addressing critical issues in crop protection.

What technology does Biotalys use for EVOCA?

EVOCA is based on Biotalys' innovative AGROBODY technology platform, showcasing its commitment to sustainable agricultural practices.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 5

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 3

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 11

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading

Top 5 Most Recently Viewed Articles

Growing Utilization of Thrombectomy Procedures: A Deep Dive

Updated Category News Views 172

Analysis Reveals Thrombectomy Trends and Implications A recent examination of Medicare data indicates a significant rise in the use of thrombectomy procedures to treat blood clots, particularly venous thromboembolic diseases. This trend, observed over several years, highlights the increasing acceptance and application of endovascular techniques in healthcare. Growth in...

Continue Reading
Cyngn Sees Significant Growth in Autonomous Vehicle Orders

Updated Category News Views 104

Cyngn’s Remarkable Growth in Vehicle Orders MOUNTAIN VIEW, Calif. — Cyngn has announced a staggering increase in the number of DriveMod Tuggers sold, tripling its sales in the previous year. This significant growth not only reflects the surging demand for autonomous vehicles but also highlights the expansion of operational activities among various enterprises....

Continue Reading
Beatbot Debuts AquaSense 2 Series at IFA 2025 Amid Recognition

Updated Category News Views 260

Introduction to Beatbot's AquaSense 2 Series Beatbot, a leading name in advanced pool cleaning technology, recently unveiled its award-winning AquaSense 2 Series at IFA 2025 held in Berlin. This innovative product line, which includes the AquaSense 2 Ultra, Pro, and standard models, is revolutionizing how households manage pool cleanliness. Acknowledgment at IFA 2025...

Continue Reading
Legal-Bay Enhances Support for Railroad Injury Claims Today

Updated Category News Views 237

Legal-Bay's Commitment to Railroad Injury Victims Legal-Bay is a leading pre-settlement funding company dedicated to helping victims of train accidents and railroad injuries. Recently, there has been a renewed focus on claims related to Federal Employers Liability Act (FELA) and cases involving Norfolk Southern Railroad, among others. With an uptick in applications from...

Continue Reading
New Bill Proposes Extended Funding for National Parks Maintenance

Updated Category News Views 228

New Legislation Aims to Secure Funding for National Parks The National Parks Conservation Association (NPCA) is excited about the reintroduction of a bill designed to provide essential maintenance funding for national parks and public lands across the nation. This initiative is rooted in the recognition that our national parks need substantial investment to thrive and...

Continue Reading